Equities

Perseus Proteomics Inc

4882:TYO

Perseus Proteomics Inc

Actions
  • Price (JPY)627.00
  • Today's Change-15.00 / -2.34%
  • Shares traded524.40k
  • 1 Year change+46.50%
  • Beta1.2174
Data delayed at least 20 minutes, as of Nov 13 2024 05:43 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments1,5412,4453,215
Total Receivables, Net845145
Total Inventory4.413.183.29
Prepaid expenses8.561527
Other current assets, total130.010.22
Total current assets1,6512,5153,291
Property, plant & equipment, net000
Goodwill, net------
Intangibles, net000
Long term investments------
Note receivable - long term------
Other long term assets43529.72
Total assets1,6942,5673,301
LIABILITIES
Accounts payable------
Accrued expenses572912
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total7182137
Total current liabilities129111148
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total166590.00
Total liabilities295170148
SHAREHOLDERS EQUITY
Common stock1,9711,9391,939
Additional paid-in capital2,2572,2252,225
Retained earnings (accumulated deficit)(2830)(1768)(1012)
Treasury stock - common(0.02)(0.02)--
Unrealized gain (loss)------
Other equity, total0.00----
Total equity1,3982,3973,152
Total liabilities & shareholders' equity1,6942,5673,301
Total common shares outstanding121212
Treasury shares - common primary issue0.000.000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.